Stockreport

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

Nuvation Bio Inc. Class A  (NUVB) 
PDF NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on solving some of the toughest challenges in cancer treatment, will ann [Read more]